Elevance Health, Inc.
ELV
$342.93
-$5.25-1.51%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.10% | 11.93% | 9.66% | 4.81% | 1.06% |
| Total Other Revenue | 5.56% | 12.09% | 13.02% | 16.31% | 14.75% |
| Total Revenue | 12.62% | 11.96% | 10.21% | 6.63% | 3.19% |
| Cost of Revenue | 16.19% | 14.56% | 12.52% | 6.64% | 2.60% |
| Gross Profit | 3.37% | 5.24% | 4.37% | 6.58% | 4.75% |
| SG&A Expenses | 8.19% | 12.83% | 9.01% | 10.11% | 7.08% |
| Depreciation & Amortization | 8.28% | 4.38% | -14.57% | -19.19% | -34.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.31% | 14.13% | 11.59% | 7.31% | 3.40% |
| Operating Income | -15.88% | -20.21% | -10.81% | -4.14% | -0.26% |
| Income Before Tax | -15.11% | -14.44% | -17.62% | -3.40% | 2.45% |
| Income Tax Expenses | -45.73% | -17.64% | -9.48% | 3.17% | 12.12% |
| Earnings from Continuing Operations | -5.19% | -13.48% | -19.94% | -5.29% | -0.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -88.89% | -82.76% | 10.00% | 37.50% | 325.00% |
| Net Income | -5.32% | -13.79% | -19.89% | -5.24% | -0.12% |
| EBIT | -15.88% | -20.21% | -10.81% | -4.14% | -0.26% |
| EBITDA | -12.55% | -16.95% | -9.75% | -5.09% | -3.25% |
| EPS Basic | -2.23% | -11.07% | -17.77% | -3.21% | 1.71% |
| Normalized Basic EPS | -18.17% | -23.15% | -12.60% | -4.98% | -0.01% |
| EPS Diluted | -1.92% | -10.83% | -17.61% | -3.14% | 1.74% |
| Normalized Diluted EPS | -17.98% | -23.00% | -12.51% | -4.96% | -0.02% |
| Average Basic Shares Outstanding | -3.36% | -2.85% | -2.29% | -2.00% | -1.84% |
| Average Diluted Shares Outstanding | -3.57% | -3.06% | -2.42% | -2.07% | -1.90% |
| Dividend Per Share | 4.91% | 6.12% | 7.40% | 8.73% | 10.14% |
| Payout Ratio | 0.07% | 0.19% | 0.31% | 0.12% | 0.08% |